[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 693 8447", "website": "https://galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.05, "dayLow": 1.01, "dayHigh": 1.0699, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.05, "regularMarketDayLow": 1.01, "regularMarketDayHigh": 1.0699, "payoutRatio": 0.0, "beta": 0.281, "forwardPE": -1.0097088, "volume": 38836, "regularMarketVolume": 38836, "averageVolume": 119590, "averageVolume10days": 68810, "averageDailyVolume10Day": 68810, "bid": 1.01, "ask": 1.09, "bidSize": 1, "askSize": 1, "marketCap": 5862777, "fiftyTwoWeekLow": 1.01, "fiftyTwoWeekHigh": 3.61, "allTimeHigh": 4870.8, "allTimeLow": 1.04, "fiftyDayAverage": 1.40428, "twoHundredDayAverage": 1.662785, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -15012828, "profitMargins": 0.0, "floatShares": 5229815, "sharesOutstanding": 5479231, "sharesShort": 5280, "sharesShortPriorMonth": 34355, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.001, "heldPercentInsiders": 0.01193, "heldPercentInstitutions": 0.0136, "shortRatio": 0.07, "shortPercentOfFloat": 0.001, "impliedSharesOutstanding": 5637286, "bookValue": 3.87, "priceToBook": 0.26873386, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8722000, "trailingEps": -5.61, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 2.149, "52WeekChange": -0.6360544, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.04, "recommendationKey": "none", "totalCash": 20528000, "totalCashPerShare": 3.871, "ebitda": -6986500, "totalDebt": 0, "quickRatio": 8.658, "currentRatio": 8.709, "returnOnAssets": -0.24211, "returnOnEquity": -0.53989, "freeCashflow": -3760750, "operatingCashflow": -5468000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestampStart": 1756238400, "earningsTimestampEnd": 1756756800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.61, "epsForward": -1.03, "fiftyDayAverageChange": -0.36428, "fiftyDayAverageChangePercent": -0.25940695, "twoHundredDayAverageChange": -0.6227851, "twoHundredDayAverageChangePercent": -0.37454337, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "postMarketChangePercent": 0.9615376, "postMarketPrice": 1.05, "postMarketChange": 0.00999999, "regularMarketChange": -0.03000009, "regularMarketDayRange": "1.01 - 1.0699", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 119590, "fiftyTwoWeekLowChange": 0.029999971, "fiftyTwoWeekLowChangePercent": 0.029702943, "fiftyTwoWeekRange": "1.01 - 3.61", "fiftyTwoWeekHighChange": -2.57, "fiftyTwoWeekHighChangePercent": -0.7119114, "fiftyTwoWeekChangePercent": -63.60544, "marketState": "CLOSED", "regularMarketChangePercent": -2.8037467, "regularMarketPrice": 1.04, "corporateActions": [], "postMarketTime": 1763167758, "regularMarketTime": 1763154000, "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]